Results 201 to 210 of about 572,501 (357)
Grading of bladder cancer: updates, controversies and practical solutions. [PDF]
Downes MR +3 more
europepmc +1 more source
Potential of Proteases in the Diagnosis of Bladder Cancer. [PDF]
Guszcz T +3 more
europepmc +1 more source
AI‐Assisted Bioelectronics for Personalized Health Management
Recent advances in artificial intelligence (AI)‐assisted bioelectronics, including materials, device fabrication, working mechanisms, AI‐hardware integration, and proof‐of‐concept applications in digital health management, are summarized. The emergence of AI‐assisted bioelectronic systems and potential solutions to existing challenges are discussed ...
Huiwen Xiong +6 more
wiley +1 more source
The Urinary Microbiota and the Gut-Bladder Axis in Bladder Cancer. [PDF]
Butt UA, De Biase D.
europepmc +1 more source
Intraoperative ICG fluorescence imaging demonstrated that bladder perfusion was maintained through blood flow from the pubic side, even after complete division of the internal iliac vessels during total pelvic exenteration. ABSTRACT Background In lateral lymph node dissection (LLND) for locally advanced or recurrent rectal cancer, concomitant resection
Mamoru Uemura +14 more
wiley +1 more source
The infection-microbiome-immunity axis in bladder cancer: mechanistic insights and therapeutic perspectives. [PDF]
Pan S +5 more
europepmc +1 more source
RRM2 Is a Putative Biomarker and Promotes Bladder Cancer Progression via PI3K/AKT/mTOR Pathway [PDF]
Linfa Guo +8 more
openalex +1 more source
In advanced colorectal cancer, tumors with mature tertiary lymphoid structures (TLS) exhibited abundant infiltration of CD3‐ and CD8‐positive lymphocytes in both primary and metastatic sites, indicating an activated immune response. The presence of mature TLS was also associated with favorable chemotherapy sensitivity and improved prognosis.
Nobuhiro Hosoi +9 more
wiley +1 more source
Clinical trial landscape of cellular therapies in bladder cancer. [PDF]
Zhang Y, Lv S, Li Z, Wang X, Zhu Y.
europepmc +1 more source

